FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/083224 [Registered on: 24/03/2025] Trial Registered Prospectively
Last Modified On: 21/03/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparing the effects of Gomutra Haritaki and Atorvastatin on Weight Loss in people with obesity. 
Scientific Title of Study   Evaluation of Comparative Efficacy of Gomutra Haritaki Yog and Atorvastatin in the management of Obesity-(Sthoulya) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sakshi Krushnaji Mute 
Designation  BAMS Intern 
Affiliation  Mahatma Gandhi Ayurved College Hospital and Research Center 
Address  Room No 35 Mahatama Gandhi Ayurved College Hospital And Research Centre. Salod H , Wardha ,Maharashtra , India 442001
Room No 35 Mahatama Gandhi Ayurved College Hospital And Research Centre Salod H , Wardha ,Maharashtra , India 442001
Wardha
MAHARASHTRA
442001
India 
Phone  9834288643  
Fax    
Email  mutesakshi@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Sakshi Krushnaji Mute 
Designation  BAMS Intern 
Affiliation  Mahatma Gandhi Ayurved College Hospital and Research Center 
Address  Room No 35 Mahatama Gandhi Ayurved College Hospital And Research Centre , Wardha ,Maharashtra,India 442001
Room No 35 Mahatama Gandhi Ayurved College Hospital And Research Centre , Wardha ,Maharashrtra , India 442001
Wardha
MAHARASHTRA
442001
India 
Phone  9834288643  
Fax    
Email  mutesakshi@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shweta Parwe 
Designation  Professor and HOD department of Panchkarma 
Affiliation  Mahatma Gandhi Ayurved College Hospital and Research Center 
Address  Room No 35 Mahatama Gandhi Ayurved College Hospital And Research Centre Wardha Maharashtra India 442001
Room No 35 Mahatama Gandhi Ayurved College Hospital And Research Centre Wardha Maharashtra India 442001
Wardha
MAHARASHTRA
442001
India 
Phone  9511659185  
Fax    
Email  shweta.parwe@dmiher.edu.in  
 
Source of Monetary or Material Support  
Mahatma Gandhi Ayurved College Hospital and Research Centre ,Salod Hirapur Wardha 442001 Maharashtra India 
 
Primary Sponsor  
Name  Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Hirapur Wardha 
Address  Room no 35 Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Hirapur Wardha  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Sakshi Mute  Mahatma Gandhi Ayurved College Hospital and Research Centre  Room No 35 Mahatama Gandhi Ayurved College Hospital And Research Centre Wardha ,Maharashtra ,India
Wardha
MAHARASHTRA 
9834288643

mutesakshi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Mahatma Gandhi Ayurved College Hospital and Research Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E669||Obesity, unspecified. Ayurveda Condition: MEDOJA-VRUDDHIH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Tablet Atrovastatin Tab Atrovastatin will be adminstered 10 mg OD for 2 months in the morning .
2Intervention ArmDrugClassical(1) Medicine Name: Gomutra Haritaki , Reference: -, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1500(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: Luke warm water), Additional Information: Gomutra HAritaki will be administered twice a day for 2 months in 15 patients
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  Patient of obesity will be recruited as per ICD Criteria for Obesity Subjects willing to participate in the study and sign the written informed consent Subjects between age group of 20 to 40 years of either sex Subjects having BMI more than or equal to 30 to 40 kg per m2
 
 
ExclusionCriteria 
Details  Known case of Hypothyroidism Diabetes mellitus Cardiovascular Renal Disorder and Drug induced Obesity etc
Pregnant lady and Lactating mother
Any other illness developed during treatment
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
To asses the Efficacy of Gomutra Haritaki Yog and Atorvastatin over Weight BMI weight in kg per height in metre square Hip Waist ratio Lipid Profile
 
At 0 days ,15 days , 1 month, 2 month
 
 
Secondary Outcome  
Outcome  TimePoints 
Comparison and assesment of Efficacy of Gomutra Haritaki Yog and Atorvastatin in Weight BMI weight in kg per height in metre square Hip Waist ratio Lipid Profile
 
60 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   the volunteers will be informed about the study protocol. Willing participants will be randomly selected as per computer generated table. Clinical research format will be prepared and validated. Prior to the study approval will be taken from IEC, MGACHRC, Salod (H) Wardha and CTRI registration will be done. After selection, each participant will be tested individually and selected according to selection criteria. They are divided into two groups the trial is a two arm parallel group, randomized, single blind clinical, standard controlled trial. it will include a 2 months treatment period and at 15th day , 1month ,2 month follow up period 
Close